Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
NCT04830371
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
444
Enrollment
INDUSTRY
Sponsor class
Conditions
Typhoid Fever
Interventions
BIOLOGICAL:
EuTCV (Vi-CRM Typhoid conjugate vaccine)
BIOLOGICAL:
Typbar-TCV
Sponsor
EuBiologics Co.,Ltd